Medication administration, lab order follow-up, and psychotropic monitoring failures
Summary
The facility failed to ensure a resident received cholecalciferol as ordered when an LVN did not clarify the medication during administration and then documented it as given on the MAR even though it was not administered. The resident had diagnoses including protein-calorie malnutrition, generalized muscle weakness, and generalized osteoarthritis, and was cognitively intact with capacity to understand and make decisions. During the observed medication pass, the LVN prepared and administered other medications but did not give the cholecalciferol. She later stated she was confused by the order and the house supply medications, did not want to risk giving the wrong medication, and documented incorrectly. The DON stated the medication should have been clarified during the medication administration timeframe and that the resident did not receive the daily dose. The facility also failed to carry out a physician order for a UA with C&S for a resident with diabetes, Alzheimer’s disease, muscle weakness, and neuromuscular dysfunction of the bladder. The resident had a change in condition with getting up unassisted, yelling, and combative and aggressive behaviors, and the physician ordered the urine testing. The order was not properly entered into the physician orders, was not visible to assigned nurses, and there was no documentation showing endorsement, attempts to obtain the specimen, or follow-up. RN staff stated they were not made aware of the pending order because it was not endorsed or documented in a way that allowed follow-up, and the DON stated the order was not properly inputted and should have had an end date to ensure awareness. The facility further failed to monitor a resident receiving haloperidol 4 mg twice daily for sedation and related side effects. The resident had COPD, muscle weakness, dysphagia, and dementia, and was severely cognitively impaired and dependent on staff for toileting, bathing, and dressing. The care plan and psychotropic risk form identified sedation as a risk and indicated monitoring for adverse reactions such as sedation and dizziness, but the MAR did not show monitoring for sedation. During observation, the resident was found asleep in bed and did not respond to verbal stimuli until repeated attempts and tactile stimulation, including a sternal rub. The DON stated monitoring for sedation was important due to the risk for falls or excessive sedation and to allow the physician to be notified if medication adjustments were needed.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.